SP1 and diabetes mellitus: In diabetes-associated vascular dysfunction, miR-21 stimulated the proliferation of vascular smooth muscle cells (VSMC) by targeting specificity protein-1 (SPI) [28] and protected endothelial cells against high glucose-induced endothelial cytotoxicity probably by inhibiting the expression of the death domain-associated protein (DAXX) [29].